Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

The cost of alcohol in the workplace in Belgium.

Tecco J, Jacques D, Annemans L.

Psychiatr Danub. 2013 Sep;25 Suppl 2:S118-23. Review.

2.

Costs of employee smoking in the workplace in Scotland.

Parrott S, Godfrey C, Raw M.

Tob Control. 2000 Jun;9(2):187-92.

3.

[Illicit drug use among employees in Belgium: an initial estimate of the costs borne by employers].

Tecco J, Bongaerts X, Annemans L.

Rev Med Brux. 2014 Sep-Oct;35(5):411-5. French.

PMID:
25672009
4.

Prevention of alcohol misuse among children, youths and young adults.

Korczak D, Steinhauser G, Dietl M.

GMS Health Technol Assess. 2011;7:Doc04. doi: 10.3205/hta000095. Epub 2011 Jul 22.

5.

[Cost-benefit analysis of primary prevention programs for mental health at the workplace in Japan].

Yoshimura K, Kawakami N, Tsusumi A, Inoue A, Kobayashi Y, Takeuchi A, Fukuda T.

Sangyo Eiseigaku Zasshi. 2013;55(1):11-24. Epub 2012 Dec 21. Japanese.

6.

[Legislation concerning alcohol and drug intake in the workplace].

Goszczyńiska E.

Med Pr. 2013;64(4):593-608. Review. Polish.

PMID:
24502123
7.

Prevalence and consequences of smoking, alcohol use, and illicit drug use at five worksites.

French MT, Zarkin GA, Hartwell TD, Bray JW.

Public Health Rep. 1995 Sep-Oct;110(5):593-9.

8.

Do drug-free workplace programs prevent occupational injuries? Evidence from Washington State.

Wickizer TM, Kopjar B, Franklin G, Joesch J.

Health Serv Res. 2004 Feb;39(1):91-110.

9.

Workplace drug abuse policy.

McGuire TG, Ruhm CJ.

J Health Econ. 1993 Apr;12(1):19-38.

PMID:
10171449
10.

Intoxicated workers: findings from a national Australian survey.

Pidd K, Roche AM, Buisman-Pijlman F.

Addiction. 2011 Sep;106(9):1623-33. doi: 10.1111/j.1360-0443.2011.03462.x. Epub 2011 Jun 28.

PMID:
21711404
11.

[Economic impact according to health problems of workers].

Lee YM, Jung MH.

Taehan Kanho Hakhoe Chi. 2008 Aug;38(4):612-9. Korean.

PMID:
18753813
12.

Migraine disorder: workplace implications and solutions.

Berry PA.

AAOHN J. 2007 Feb;55(2):51-6. Review.

PMID:
17323870
13.

[Vigilance in application of law 125/2001 concerning alcohol and alcohol-related risk assessment in workplaces].

Cornaggia N, Saretto G, Tiso C, Caironi M.

Med Lav. 2007 Nov-Dec;98(6):487-92. Italian.

PMID:
18041469
14.

Substance abuse in the workplace: epidemiology, effects, and industry response.

Bush DM, Autry JH 3rd.

Occup Med. 2002 Jan-Mar;17(1):13-25, iii. Review.

PMID:
11726333
15.

Workplace smoking related absenteeism and productivity costs in Taiwan.

Tsai SP, Wen CP, Hu SC, Cheng TY, Huang SJ.

Tob Control. 2005 Jun;14 Suppl 1:i33-7.

17.

The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm.

Kessler RC, Lane M, Stang PE, Van Brunt DL.

Psychol Med. 2009 Jan;39(1):137-47. doi: 10.1017/S0033291708003309. Epub 2008 Apr 21.

PMID:
18423074
18.

The role of the workplace in the production and containment of health costs: the case of stress-related disorders.

Shain M.

Int J Health Care Qual Assur Inc Leadersh Health Serv. 1999;12(2-3):i-vii.

PMID:
10537851
19.

Metabolic syndrome in a workplace: prevalence, co-morbidities, and economic impact.

Schultz AB, Edington DW.

Metab Syndr Relat Disord. 2009 Oct;7(5):459-68. doi: 10.1089/met.2009.0008.

20.

Health promotion programme in the private workplaces in Singapore: a prevalence survey.

Chew L, Cheah C, Koh YH.

Singapore Med J. 2002 Jan;43(1):18-24.

PMID:
12008771

Supplemental Content

Support Center